IHealthScreen hauled in FDA 510(k) clearance for its AI-powered diagnostic that detects mild diabetic retinopathy in diabetic adults who have gone undiagnosed with the condition.
Source: FierceBiotech
You may also like
Stem Cell Therapy Shows Promise in First Human...
Ag Genomics Begins to Bear Fruit
StockWatch: Insilico Projects Profit, Revenue Leaps as...
Macrophage Membrane-Derived Nanoparticles Shows...
[Podcast] From Protocol to Patient: Inside Clinical...
Deals, deals, deals; Biohaven takes on Eli Lilly; and...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.